Santi s. ChenAssociate Director, Immunology and Oncology, GemPharmatech
Santi is a research scientist and business development professional with over 10 years of experience in autoimmune disease, immunology, and oncology disease areas. Santi received her training in human B cell development at the Garvan Institute of Medical Research Australia in Immunology, followed by a postdoctoral fellowship at the Children’s Cancer Institute Australia, focusing on pediatric leukemia and therapies. Her projects include testing agents’ efficacy and mechanisms such as navitoclax, venetoclax, and selumetinib. Her research projects resulted in multiple publications in journals such as Blood and Journal of Immunology and national/international awards.
GemPharmatech, a leading provider of mouse models and preclinical services, offers a one-stop solution for in vivo studies with a collection of more than 20,000 strains including KO/cKO, humanized, disease, germ-free and custom models, as well as custom breeding services.
Sponsored by GemPharmatech; Contact: sales@gempharmatech.us